Animalcare Group plc
(''Animalcare'', "the Company" or "the Group")
Result of 2024 AGM and Board Changes
20 June 2024. As announced on 9 April 2024 by Animalcare Group plc (AIM: ANCR), at the conclusion of today's Annual General Meeting ("AGM"), Jan Boone stepped down from the Board and Ed Torr, previously Senior Independent Director, succeeded Jan as Chair. The Board has also reviewed the composition of its Committees and agreed that Sylvia Metayer will take on the role of Senior Independent Director and Dr Doug Hutchens will chair the Remuneration & Nomination Committee. These changes take place with immediate effect.
Animalcare Group plc confirms that all the resolutions put to the AGM today were duly passed. All resolutions were decided on a poll. Resolutions 1 to 12 were passed as ordinary resolutions and resolutions 13 to 15 were passed as special resolutions. The voting results are given below.
|
No |
Resolution |
Votes FOR (including discretionary) |
% |
Votes AGAINST |
% |
% of ISC Voted |
Votes WITHHELD |
|
1 |
To receive the audited annual accounts of the Company for the year ended 31 December 2023 together with the directors' report and the auditors' report on those annual accounts. |
44,622,675 |
100.00% |
- |
0.00% |
73.91% |
- |
|
2 |
To declare a final dividend for the year ended 31 December 2023 of 3.0 pence per ordinary share. |
44,622,675 |
100.00% |
- |
0.00% |
73.91% |
- |
|
3 |
To re-elect Mr C Brewster as a Director. |
44,621,725 |
100.00% |
- |
0.00% |
73.91% |
950 |
|
4 |
To re-elect Mr M Coucke as a Director. |
44,621,725 |
100.00% |
- |
0.00% |
73.91% |
950 |
|
5 |
To re-elect Dr D Hutchens as a Director. |
44,621,725 |
100.00% |
- |
0.00% |
73.91% |
950 |
|
6 |
To re-elect Ms S Metayer as a Director. |
44,621,725 |
100.00% |
- |
0.00% |
73.91% |
950 |
|
7 |
To re-elect Mr E Torr as a Director. |
44,551,296 |
99.84% |
70,429 |
0.16% |
73.91% |
950 |
|
8 |
To re-elect Ms J Winter as a Director |
44,621,725 |
100.00% |
- |
0.00% |
73.91% |
950 |
|
9 |
To approve the Directors' Remuneration Report as set out in the Annual Report and Accounts 2023. |
44,621,725 |
100.00% |
- |
0.00% |
73.91% |
950 |
|
10 |
To approve the appointment of Grant Thornton UK LLP as auditors of the Company. |
44,619,725 |
100.00% |
2,000 |
0.00% |
73.91% |
950 |
|
11 |
To authorise the Audit and Risk Committee to determine the remuneration of the auditors. |
44,619,725 |
100.00% |
2,000 |
0.00% |
73.91% |
950 |
|
12 |
To authorise the Directors to allot shares. |
41,320,968 |
92.60% |
3,301,707 |
7.40% |
73.91% |
- |
|
13 |
To authorise the Directors to disapply statutory pre-emption rights in respect of the Company's issued share capital. |
44,598,175 |
100.00% |
2,000 |
0.00% |
73.87% |
22,500 |
|
14 |
To authorise the Directors to disapply pre-emption rights for purposes of acquisitions or capital investments. |
41,320,968 |
92.60% |
3,301,707 |
7.40% |
73.91% |
- |
|
15 |
To authorise the Company to purchase its own shares. |
44,622,675 |
100.00%
|
- |
0.00% |
73.91% |
- |
Notes:
1. Any proxy arrangement which gave discretion to the Chairman has been included in the "For" totals.
2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
3. The number of shares in issue at 11.30am on 18 June 2024 was 60,374,268 ("ISC"). Holders of ordinary shares are entitled to one vote per share. No shares are held in treasury.
|
Enquiries:
Animalcare Group Plc Chris Brewster, Chief Financial Officer |
+44 (0)1904 487 687 communications@animalcaregroup.com |
|
|
Stifel Nicolaus Europe Limited (Nominated Advisor & Joint Broker) Ben Maddison Nicholas Harland Francis North |
+44 (0)20 7710 7600
|
|
|
Panmure Gordon (Joint Broker) Corporate Finance Freddy Crossley/Emma Earl Corporate Banking Rupert Dearden |
+44 (0)20 7886 2500 |
|
About Animalcare
Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
